PHS
GNMK

PFM Health Sciences’s GenMark Diagnostics, Inc GNMK Stock Holding History

PFM Health Sciences’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-650,015
Closed -$7.89M – 82
2013
Q3 		$7.89M Buy
650,015
+45,816
+8% +$491K 0.19% 62
2013
Q2 		$6.25M Buy
+604,199
New +$8.33M 0.13% 64

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return

PFM Health Sciences's GNMK Position: Q4 2013 in Review

PFM Health Sciences sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2013, closing a stake of 650,015 shares — an estimated $7.89M sold.

PFM Health Sciences first reported a position in GNMK in Q2 2013 and held it in 2 quarters. The position peaked at $7.89M in Q3 2013. 78 funds tracked by Wall St. Rank hold GNMK as of Q4 2013.

  • PFM Health Sciences reported no remaining GenMark Diagnostics, Inc position as of Q4 2013 after selling out during the quarter.
  • PFM Health Sciences sold 650,015 GenMark Diagnostics, Inc shares in Q4 2013, an estimated $7.89M.
  • PFM Health Sciences first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 2 quarters.
  • PFM Health Sciences's GenMark Diagnostics, Inc position peaked at $7.89M in Q3 2013.
  • 78 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2013.

Based on PFM Health Sciences's 13F filing for Q4 2013, filed 14 Feb 2014.